| Jim Sharpnack, PHD | |
|
500 Limit St, Leavenworth, KS 66048-4435 | |
| (913) 682-5118 | |
| (913) 682-4664 |
| Full Name | Jim Sharpnack |
|---|---|
| Gender | Male |
| Speciality | Psychologist |
| Location | 500 Limit St, Leavenworth, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124090121 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 1184 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jim Sharpnack, PHD 500 Limit St, Leavenworth, KS 66048-4435 Ph: (913) 682-5118 | Jim Sharpnack, PHD 500 Limit St, Leavenworth, KS 66048-4435 Ph: (913) 682-5118 |
News Archive
Today, the U.S. Food and Drug Administration approved Trogarzo (ibalizumab-uiyk), a new type of antiretroviral medication for adult patients living with HIV who have tried multiple HIV medications in the past (heavily treatment-experienced) and whose HIV infections cannot be successfully treated with other currently available therapies (multidrug resistant HIV, or MDR HIV).
Stem cells hold great promise for the medicine of the future, but they can also be a cause of disease. When these self-renewing, unspecialized cells fail to differentiate into diverse cell types, they can start dividing uncontrollably, leading to cancer. Already several decades ago, Weizmann Institute scientists were among the first to demonstrate the link between cancer and the faulty differentiation of stem cells. Now a new Weizmann Institute-led study, published in Molecular Cell, reveals a potential molecular mechanism behind this link.
Researchers at University of California, San Diego School of Medicine have established the safety and dosing of a new drug for treating blood cancers. The findings are published online July 27 in The Lancet Haematology.
In the 2020 February 25 issue of Scientific Reports, a research group from the Department of Hepatology in Osaka City University Graduate School of Medicine, Japan reported that levels of a circulating soluble immune checkpoint protein can be used as a potential marker to predict overall survival in patients with advanced HCC.
› Verified 3 days ago
Dr. Paula L. Timmons, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 4101 S 4th St, Leavenworth, KS 66048 Phone: 913-682-2000 Fax: 913-758-4273 | |
Dr. Kylie L Dowell, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4101 S 4th St, Leavenworth, KS 66048 Phone: 913-682-2000 | |
Deborah Lynn Weidinger, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 3515 S 4th Street, Professional Association, Leavenworth, KS 66048 Phone: 913-651-8415 Fax: 913-772-8580 | |
Dr. Amber D. Guzman, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4101 S 4th St, Leavenworth, KS 66048 Phone: 913-682-2000 Fax: 913-946-1561 | |
Dakota Mcnamara Thornblade, LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 500 Limit St, Leavenworth, KS 66048 Phone: 913-682-4664 | |
Dr. Erin Elisabeth Mills, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4101 S 4th St, Leavenworth, KS 66048 Phone: 913-682-2000 |